NEC Lawsuit

Similac and Enfamil Increase Risk of Necrotizing Enterocolitis (“NEC”) for Preterm Infants

AWKO Working Hard to Hold Abbott and Mead Johnson Accountable for Failing to Disclose the Risk of Necrotizing Enterocolitis (“NEC”) to Premature Infants from Cow’s Milk-Based Formula

AWKO Has Filed Cases on Behalf of Preterm Infants and Their Families Who Suffered Life-Threatening NEC

For years, the scientific community has warned that preterm infants fed cow’s milk-based formula face a significantly higher risk of NEC than those fed human breast milk.  Despite this, Abbott Laboratories and Mead Johnson, the respective manufacturers of Similac and Enfamil infant formula product lines, fail to adequately convey this increased risk to parents and physicians alike.

If you or a loved one is a parent of an infant born premature (fewer than 37 weeks) and that was diagnosed with Necrotizing Enterocolitis (“NEC”) after ingesting the following formulas, call us today:

  • Enfamil Formula
  • Similac Formula
  • Similac Human Milk Fortifier

Necrotizing Enterocolitis (“NEC”) can lead to injuries that include:

  • Intestinal perforation
  • Scarring or strictures in the intestines
  • Sepsis
  • Cerebral palsy
  • Neurological damage
  • Surgery
  • Death